What is Covetrus?
Headquartered in Portland, Maine, Covetrus operates as a comprehensive provider of integrated products, software, and services tailored for the companion, equine, and large-animal veterinary markets. Its core mission is to enhance the clinical and financial outcomes for veterinary practices through a unified platform that streamlines supply chain management, prescription services, compounded medications, and practice management software. The company's proprietary Pulse Veterinary Operating System facilitates essential functions such as scheduling, prescription fulfillment, client communication, and invoicing. Furthermore, the mycovetrus.com portal acts as a central hub for veterinary professionals to procure both office-use compounded medications and in-clinic supplies. Covetrus serves a vast network of over 100,000 customers across approximately 25 countries, leveraging more than six decades of collective experience to advance veterinary care and optimize practice performance.
How much funding has Covetrus raised?
Covetrus has raised a total of $4.7B across 3 funding rounds:
Debt
$250M
Private Equity
$4B
Debt
$425M
Debt (2020): $250M with participation from Clayton Dubilier & Rice LLC
Private Equity (2022): $4B led by Clayton, Dubilier & Rice and TPG
Debt (2022): $425M, investors not publicly disclosed
What's next for Covetrus?
The substantial enterprise-level funding and recent strategic investment signal Covetrus's commitment to continued expansion and innovation within the animal health technology landscape. This capital infusion is expected to fuel further development of its integrated platform, potentially including enhancements to its Pulse Veterinary Operating System and the mycovetrus.com portal. Strategic investments of this magnitude often indicate a focus on market consolidation, technological advancement, or geographic expansion. Covetrus is well-positioned to leverage this financing to solidify its leadership in providing essential technology and services that improve veterinary practice efficiency and patient care globally.
See full Covetrus company page
